Scientists at Rensselaer Polytechnic Institute (RPI), through biomolecular research and testing, have discovered a potential topical therapeutic to treat monkeypox. The research stems from years of study spent on investigating the structures of viruses such as zika, Dengue, herpes, coronaviruses, and hepatitis. The past research and expertise in the interaction of virus proteins and polysaccharides, including existing drugs, aided researchers in the rapid discovery of a potential therapeutic. The work is in its early stages; however, the researchers believe that because the drugs used in the work are FDA-approved, there would be a rapid pathway for clinical testing and potential approval as a monkeypox therapy. This timely research has been published in Molecules recently.